[en] As soon as the early 70's, group B streptococci (GBS) became clearly predominant in neonatal infections. There was a dramatic increase in the incidence of GBS neonatal sepsis and meningitis throughout developed countries and GBS emerged as the leading cause of severe neonatal infections. Most of these infections, associated with high mortality and morbidity, could be prevented by intrapartum chemoprophylaxis given to risk mothers. AAP, ACOG and the CDC issued guidelines for their prevention. Today, in Belgium, there are still no recommendations for the prevention of GBS early-onset infections.
Disciplines :
Reproductive medicine (gynecology, andrology, obstetrics)
Author, co-author :
Melin, Pierrette ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Microbiologie médicale et virologie médicale
Schmitz, M.
De Mol, Patrick ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Microbiologie médicale et virologie médicale
Foidart, Jean-Michel ; Université de Liège - ULiège > Département des sciences cliniques > Gynécologie - Obstétrique - Labo de biologie des tumeurs et du développement
Rigo, Jacques ; Université de Liège - ULiège > Département des sciences cliniques > Pédiatrie - Néonatologie
Language :
French
Title :
Le streptocoque du groupe B, premiere cause d'infections neonatales graves. Epidemiologie et strategies de prevention
Alternative titles :
[en] Group B Streptococcus, Primary Cause of Life-Threatening Infections in Infants. Epidemiology and Prevention Strategy
